Clinical Trials Logo
  1. Home
  2. Hepatocarcinoma
  3. NCT03356236

Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma Following Local Ablation

Hepatocarcinoma Clinical Trial

Official title:
A Multicenter, Prospective Cohort Study Investigating Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma Following Local Ablation

Clinical Trial Summary

To evaluate the efficacy and safety of Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma following Local Ablation

Clinical Trial Description

A multicenter, prospective cohort study investigating Huaier Granule for Prevention of Recurrence and Metastasis of Hepatocarcinoma following Local Ablation，to evaluate the efficacy and safety ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT03356236
Study type Observational
Source Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Contact Yue Han, Professor
Phone +0086-13511021629
Email doctorhan001@163.com
Status Recruiting
Phase
Start date April 17, 2018
Completion date December 31, 2024
View Details
See also
  Status Clinical Trial Phase
Not yet recruiting NCT06041490 - Adjuvant Therapy for High-risk Hepatocellular Carcinoma Post Liver Transplantation Phase 2
Terminated NCT03956940 - Analysis of cfDNA in Patients With Hepatocarcinoma and Treated by Sorafenib or Regorafenib N/A
Completed NCT03382327 - Benefit of the Use of 3D Models and Tools in Hepatectomy Planning for Hepatocarcinomas N/A
Recruiting NCT03755739 - Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors Phase 2/Phase 3
Recruiting NCT06028724 - A Study on the Prevalence of Clinically Useful Mutations in Solid Tumor Characterized by Next Generation Sequencing Methods on Liquid Biopsy Analysis (POPCORN)
Not yet recruiting NCT03718078 - Robotic Endomicroscopy to Better Define Resection Strategies Applied to Hepatic Surgery N/A
Recruiting NCT05794048 - METabolic PROFILE of Hepatocarcinoma and Pancreatic Tumors N/A
Recruiting NCT04435977 - Efficacy and Safety of Cabozantinib in Patients With Hepatocellular Carcinoma Phase 2
Completed NCT04811898 - A Dose Escalation Study of LNA-i-Mir-221 for Cancer Treatment Phase 1
Recruiting NCT05311319 - HAIC Combined With Anlotinib and TQB2450 as Adjuvant Therapy in HCC Patients With High Risk of Recurrence After Resection Phase 2
Completed NCT05464706 - Study on the Quality of Life (QoL) After Liver Surgery N/A
Completed NCT01411579 - Use of DwI-MR to Predict Chemotherapy Response of Liver Metastases and Hepatocarcinoma N/A
Completed NCT02519075 - 11C-Choline PET/CT and DWI MRI for Response Assessment of HCC Candidate to TARE